LONDON (Reuters) – One in three COVID-19 survivors in a study of more than 230,000 patients, mostly Americans, was diagnosed with a brain or psychiatric disorder within six months, suggesting the pandemic …
Read More »
LONDON (Reuters) – One in three COVID-19 survivors in a study of more than 230,000 patients, mostly Americans, was diagnosed with a brain or psychiatric disorder within six months, suggesting the pandemic …
Read More »
By Prapan Chankaew, Orathai Sriring PHUKET, Thailand (Reuters) – In Thailand, it is the largest tourism sector that jumped to the forefront of the COVID-19 vaccination line, and the country’s most popular …
Read More »
By Lisandra Paraguassu, Diego Vara BRASILIA / PORTO ALEGRE (Reuters) – Hospitals in Brazil’s major cities are reaching capacity, health officials warned, as the country recorded the highest death toll from COVID-19 …
Read More »
By Lisandra Paraguassu, Diego Vara BRASILIA / PORTO ALEGRE (Reuters) – Hospitals in Brazil’s major cities are reaching capacity, health officials warned, as the country recorded the highest death toll from COVID-19 …
Read More »
FILE PHOTO: An NHS poster is displayed at the Coronavirus Disease (COVID-19) Vaccination Center at Cliffs Pavilion in Southend-on-Sea, Great Britain, on February 4, 2021. REUTERS / Paul Childs (Reuters) – NHS …
Read More »
By John Miller, Ludwig Burger ZURICH (Reuters) – Vaccines from AstraZeneca, Russia’s Gamaleya Institute and Johnson & Johnson fight the coronavirus with another virus, leaving scientists concerned that the vaccines could lose …
Read More »
LONDON (Reuters) – Thousands of COVID-19 patients continue to suffer severe, debilitating and persistent symptoms many months after their initial bout of infection, with major social, health and economic consequences, European health …
Read More »
LONDON (Reuters) – England’s third nationwide COVID-19 lockdown is helping reduce infections, a study found Thursday, but the prevalence of cases remains high as Prime Minister Boris Johnson seeks a cautious route …
Read More »
PARIS (Reuters) – A candidate vaccine for COVID-19 developed by Sanofi and the US group Translate Bio “will not be ready this year,” the chief executive of the French pharmaceutical company told …
Read More »